CARONBIO

Business

We create Natural Well-being through products such as Caronbio C3 shampoo, which is made of 68% natural ingredients

Domestic

Sales

• Naver.com Smart Store
  Online open markets
  Namonae in Gangnam Station
  Welfare malls (ezwelfare, wibee, Hyundai Livart)
  Well known Hair Salons
  Well known Dermatology Clinics
  Pharmacies
  

Sponsorship

• ‘Parner’s Kitchen, Together’ (OBSw Tv Show)
  Celeb Beauty season 2 episode 10 ‘Luxury Home Care’ (KBS joy Tv Show)
  Beauty and Booty season 5 episode 10 ‘The hope of the Bald’ (DongA Tv Show)
  

Press

• “C3 Shampoo & Hair Tonic, achieves Excellent 5 Star” (MBN News / 20.10.21)
  “Caronbio Shampoo & Hair Tonic, proves anti-hairloss and hair regrowth effects” (MBN News / 20.09.01)
  The Korea Economic Daily, The Kyunghyand Shinmun, Donga, Chosun etc.
  

Completed R&D (Domestic)

• “In-vitro efficacy test of Caron Solution for hair loss and hair growth” (Biotoxtech 20.05.25)
  Scalp Safety Clinical Test “Evaluation of Primary Scalp Irritation” (Korea Institute of Dermatological Sciences 20.09.17)
  “Test fir the Antioxidant, Anti-inflammatory effects of Caron Solution” (Korea Institute of Dermatological Sciences 20.12.24)
  

Under R&D (Domestic)

• Anti hair loss and hair regrowth clinical test by Korean tertiary general hospital
  

Thesis Presentations

• “Anti Hair Loss and Hair Regrowth Mechanism” SCIE Level thesis presentation by domestic prestigious university
  

Development

• Development of the manufacturing technology of Caron Solution, ‘micro-nano-droplets’.
  

Overseas

Export

• Under export negotiations with China, Japan, USA, EU, UK, Malaisa, Australia, New Zealand
  

Cosmetic Registrations

• China: CFDA (China) registered / registering NMPA
  USA: FDA OTC registered
  Registering CPNP(EU), SCPN(UK), NPRA(Malaisa), PMDA(Japan)
  

Completed R&D (Overseas)

• Dermatest Skin Compatibility clinical test (Germany)
  Dermatest Trichoscan (Anti hair loss, hair regrowth) (Germany)
  

Under R&D (Overseas)

• Anti-Hair loss and hair regrowth human clinical trial by Harvard Massachusetts General Hospital